The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine
Authors
Keywords
-
Journal
BIOTECHNOLOGY AND BIOENGINEERING
Volume 111, Issue 12, Pages 2398-2406
Publisher
Wiley
Online
2014-06-11
DOI
10.1002/bit.25311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bioengineering virus-like particles as vaccines
- (2013) Linda H.L. Lua et al. BIOTECHNOLOGY AND BIOENGINEERING
- Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
- (2013) Christina Schellenbacher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Human Papillomavirus (HPV)In VitroNeutralization Assay That Recapitulates theIn VitroProcess of Infection Provides a Sensitive Measure of HPV L2 Infection-Inhibiting Antibodies
- (2012) Patricia M. Day et al. Clinical and Vaccine Immunology
- Affinity-based selection and the germinal center response
- (2012) Tyani D. Chan et al. IMMUNOLOGICAL REVIEWS
- Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
- (2012) Karen Nieto et al. PLoS One
- VLPs Displaying a Single L2 Epitope Induce Broadly Cross-Neutralizing Antibodies against Human Papillomavirus
- (2012) Ebenezer Tumban et al. PLoS One
- Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
- (2012) D. R. Burton et al. SCIENCE
- Developments in virus-like particle-based vaccines for infectious diseases and cancer
- (2011) Luigi Buonaguro et al. Expert Review of Vaccines
- Peptide Epitope Identification by Affinity Selection on Bacteriophage MS2 Virus-Like Particles
- (2011) Bryce Chackerian et al. JOURNAL OF MOLECULAR BIOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
- (2011) Ebenezer Tumban et al. PLoS One
- Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses
- (2011) Zoe Hunter et al. VACCINE
- Pathology and epidemiology of HPV infection in females
- (2010) Margaret Stanley GYNECOLOGIC ONCOLOGY
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7
- (2010) Jerri do Carmo Caldeira et al. VACCINE
- Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
- (2009) Balasubramanyam Karanam et al. IMMUNOLOGY AND CELL BIOLOGY
- Immunogenic Display of Diverse Peptides on Virus-like Particles of RNA Phage MS2
- (2008) David S. Peabody et al. JOURNAL OF MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now